These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15677429)

  • 1. The number of previous depressive episodes is positively associated with cortisol response to fenfluramine administration.
    Sher L; Oquendo MA; Galfalvy HC; Cooper TB; Mann JJ
    Ann N Y Acad Sci; 2004 Dec; 1032():283-6. PubMed ID: 15677429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?
    Park SB; Williamson DJ; Cowen PJ
    Int Clin Psychopharmacol; 1995 Nov; 10(4):215-20. PubMed ID: 8748042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher cortisol levels in spring and fall in patients with major depression.
    Sher L; Oquendo MA; Galfalvy HC; Zalsman G; Cooper TB; Mann JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):529-34. PubMed ID: 15866354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from major depression is not associated with normalization of serotonergic function.
    Flory JD; Mann JJ; Manuck SB; Muldoon MF
    Biol Psychiatry; 1998 Mar; 43(5):320-6. PubMed ID: 9513746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
    Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls.
    Sher L; Oquendo MA; Li S; Ellis S; Brodsky BS; Malone KM; Cooper TB; Mann JJ
    Psychoneuroendocrinology; 2003 May; 28(4):559-73. PubMed ID: 12689612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fenfluramine on episodic ACTH and cortisol secretion.
    Schürmeyer TH; Brademann G; von zur Mühlen A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):39-45. PubMed ID: 8796137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.
    Maes M; D'Hondt P; Suy E; Minner B; Vandervorst C; Raus J
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):781-90. PubMed ID: 1662403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to dl-fenfluramine challenge before and after treatment with paroxetine.
    Dulchin MC; Oquendo MA; Malone KM; Ellis SP; Li S; Mann JJ
    Neuropsychopharmacology; 2001 Sep; 25(3):395-401. PubMed ID: 11522467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
    Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age effects on cortisol levels in depressed patients with and without comorbid post-traumatic stress disorder, and healthy volunteers.
    Sher L; Oquendo MA; Galfalvy HC; Cooper TB; Mann JJ
    J Affect Disord; 2004 Oct; 82(1):53-9. PubMed ID: 15465576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in concentration of waking salivary cortisol in recovered patients with depression.
    Bhagwagar Z; Hafizi S; Cowen PJ
    Am J Psychiatry; 2003 Oct; 160(10):1890-1. PubMed ID: 14514508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P; Smythe G
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study.
    Bockting CL; Lok A; Visser I; Assies J; Koeter MW; Schene AH;
    Psychiatry Res; 2012 Dec; 200(2-3):281-7. PubMed ID: 22503382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis dysfunction in depression: correlation with monoamine system abnormalities.
    Mokrani MC; Duval F; Crocq MA; Bailey P; Macher JP
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S63-8. PubMed ID: 9264149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.